ATE437949T1 - Gpr8 ligand und dafuer kodierende dna - Google Patents
Gpr8 ligand und dafuer kodierende dnaInfo
- Publication number
- ATE437949T1 ATE437949T1 AT01941117T AT01941117T ATE437949T1 AT E437949 T1 ATE437949 T1 AT E437949T1 AT 01941117 T AT01941117 T AT 01941117T AT 01941117 T AT01941117 T AT 01941117T AT E437949 T1 ATE437949 T1 AT E437949T1
- Authority
- AT
- Austria
- Prior art keywords
- gpr8
- ligand
- dna coding
- dna
- gpr8 ligand
- Prior art date
Links
- 101000603411 Homo sapiens Neuropeptides B/W receptor type 2 Proteins 0.000 title abstract 5
- 102100038843 Neuropeptides B/W receptor type 2 Human genes 0.000 title abstract 5
- 239000003446 ligand Substances 0.000 title abstract 3
- 239000003814 drug Substances 0.000 abstract 2
- 208000008589 Obesity Diseases 0.000 abstract 1
- 102000003946 Prolactin Human genes 0.000 abstract 1
- 108010057464 Prolactin Proteins 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 239000002948 appetite stimulant Substances 0.000 abstract 1
- 229940029995 appetite stimulants Drugs 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 230000003449 preventive effect Effects 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 229940097325 prolactin Drugs 0.000 abstract 1
- 238000001525 receptor binding assay Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Child & Adolescent Psychology (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000191089 | 2000-06-21 | ||
| JP2000275013 | 2000-09-06 | ||
| JP2001116000 | 2001-04-13 | ||
| PCT/JP2001/005257 WO2001098494A1 (fr) | 2000-06-21 | 2001-06-20 | Ligand de gpr8 et son adn |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE437949T1 true ATE437949T1 (de) | 2009-08-15 |
Family
ID=27343845
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01941117T ATE437949T1 (de) | 2000-06-21 | 2001-06-20 | Gpr8 ligand und dafuer kodierende dna |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US7193033B2 (de) |
| EP (1) | EP1293567B1 (de) |
| AT (1) | ATE437949T1 (de) |
| AU (1) | AU2001274562A1 (de) |
| CA (1) | CA2413195C (de) |
| DE (1) | DE60139399D1 (de) |
| WO (1) | WO2001098494A1 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1394543B1 (de) * | 2001-05-15 | 2007-08-29 | Takeda Pharmaceutical Company Limited | Screening-verfahren |
| US7268212B2 (en) | 2001-06-14 | 2007-09-11 | Takeda Pharmaceutical Company Limited | Ligand of G protein-coupled receptor protein and DNA thereof |
| WO2003057236A1 (fr) * | 2001-12-28 | 2003-07-17 | Takeda Chemical Industries, Ltd. | Inhibiteur de prise de poids corporel |
| AU2003212356A1 (en) * | 2002-03-26 | 2003-10-08 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with homo sapiens g - protein - coupled receptor 8 (gpr8) |
| WO2003082907A1 (en) * | 2002-03-29 | 2003-10-09 | Euroscreen Sa | Ligands for g protein coupled receptor gpr7 and uses thereof |
| AU2003277553A1 (en) * | 2002-11-06 | 2004-06-07 | Takeda Pharmaceutical Company Limited | Antidiuretics |
| JP2004292444A (ja) * | 2003-03-13 | 2004-10-21 | Takeda Chem Ind Ltd | 上部消化管疾患の予防・治療剤 |
| JP4504098B2 (ja) * | 2003-05-28 | 2010-07-14 | 武田薬品工業株式会社 | 抗体およびその用途 |
| EP1627888A4 (de) * | 2003-05-28 | 2007-04-18 | Takeda Pharmaceutical | Antikörper und dessen verwendung |
| BRPI0720219A2 (pt) * | 2006-12-08 | 2013-12-24 | Univ Iowa State Res Found Inc | Genes de planta envolvidos em absorção e metabolismo de nitrato |
| WO2009033739A2 (en) * | 2007-09-11 | 2009-03-19 | Mondobiotech Laboratories Ag | Use of a peptide as a therapeutic agent |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5350836A (en) * | 1989-10-12 | 1994-09-27 | Ohio University | Growth hormone antagonists |
| US5591602A (en) * | 1993-11-05 | 1997-01-07 | O'dowd; Brian F. | Nucleic acid encoding opioid receptor |
| JPH09121865A (ja) * | 1995-10-30 | 1997-05-13 | Takeda Chem Ind Ltd | 新規ｇ蛋白質共役型レセプター蛋白質、その製造法および用途 |
| US6555339B1 (en) * | 1997-04-14 | 2003-04-29 | Arena Pharmaceuticals, Inc. | Non-endogenous, constitutively activated human protein-coupled receptors |
| US20050209447A1 (en) * | 2000-07-25 | 2005-09-22 | Takashi Ito | Process for producing recombinant protein |
| WO2002044368A1 (fr) * | 2000-11-30 | 2002-06-06 | Takeda Chemical Industries, Ltd. | Nouvelles proteines du recepteur couple a la proteine g et leurs adn |
| EP1394543B1 (de) * | 2001-05-15 | 2007-08-29 | Takeda Pharmaceutical Company Limited | Screening-verfahren |
-
2001
- 2001-06-20 EP EP01941117A patent/EP1293567B1/de not_active Expired - Lifetime
- 2001-06-20 CA CA2413195A patent/CA2413195C/en not_active Expired - Fee Related
- 2001-06-20 US US10/311,019 patent/US7193033B2/en not_active Expired - Fee Related
- 2001-06-20 WO PCT/JP2001/005257 patent/WO2001098494A1/ja active Application Filing
- 2001-06-20 DE DE60139399T patent/DE60139399D1/de not_active Expired - Lifetime
- 2001-06-20 AT AT01941117T patent/ATE437949T1/de not_active IP Right Cessation
- 2001-06-20 AU AU2001274562A patent/AU2001274562A1/en not_active Abandoned
-
2007
- 2007-01-26 US US11/699,352 patent/US7671174B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US7193033B2 (en) | 2007-03-20 |
| CA2413195A1 (en) | 2002-12-17 |
| EP1293567A4 (de) | 2005-02-16 |
| WO2001098494A1 (fr) | 2001-12-27 |
| DE60139399D1 (de) | 2009-09-10 |
| AU2001274562A1 (en) | 2002-01-02 |
| EP1293567B1 (de) | 2009-07-29 |
| CA2413195C (en) | 2012-01-17 |
| US7671174B2 (en) | 2010-03-02 |
| EP1293567A1 (de) | 2003-03-19 |
| US20080305998A1 (en) | 2008-12-11 |
| US20050153391A1 (en) | 2005-07-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE437949T1 (de) | Gpr8 ligand und dafuer kodierende dna | |
| HUP0402315A2 (hu) | VII-es faktor polipeptidek folyékony gyógyszerkészítménye | |
| ATE297925T1 (de) | 3-substituierte oxindol beta 3 agonisten | |
| IS6785A (is) | EP4 viðtakahindrar til meðhöndlunar á liðagigt | |
| ATE337191T1 (de) | Doppelbrechende markierung | |
| DE69022150D1 (de) | Neue Peptidasen und Isomerasen-Inhibitoren. | |
| HUP0402029A2 (hu) | Peptidalapú multimer célzott kontrasztanyagok | |
| DK1576112T3 (da) | Cytokin-receptor zcytor17-multimerer | |
| DK15589D0 (da) | Kemiske forbindelser | |
| SE8801275D0 (sv) | New uses of dopamine agonists | |
| ITMI20020773A0 (it) | Farmaci per il trattamento dell'artrite | |
| ATE390482T1 (de) | Interleukin-1 hy2. mittel und verfahren | |
| ATE548350T1 (de) | N-arylpiperidin-substituierte biphenylcarbonsäureamide als inhibitoren von apolipoprotein b | |
| DE60332579D1 (de) | Prozess zur Immobilisierung von Polypeptiden über die Carboxylgruppe des C-terminus | |
| BRPI0408117A (pt) | compostos heterocìclicos bifuncionais e métodos de produção e uso dos mesmos | |
| DE60021196D1 (de) | Apoptose induzierende proteinesubstanz | |
| DE60015098D1 (de) | 3-cyclopropylmethoxy-4-difluormethoxy-n-(3,5-dichlor-pyrid-4-yl)-benzamid zur behandlung von multipler sklerose | |
| BR9812531A (pt) | Combinação de componentes, preparação farmacêutica, produção desta, e, uso da combinação ou da preparação farmacêutica | |
| FI900083A (fi) | Nya tetralinderivat. | |
| ATE139570T1 (de) | Expression signalpeptid-freier staphylokinasen | |
| ATE424411T1 (de) | Varianten von säugerprolactin | |
| NO20002408D0 (no) | 5-HT1F antagonister | |
| WO2002102847A1 (fr) | Nouveau ligand et son adn | |
| ATE270551T1 (de) | Kombinationspräparat aus 2-methylthiazolidin-2,4- dicarbonsäure und paracetamol | |
| ATE308513T1 (de) | Naphthamid-neurokinin antagonisten zur verwendung als medikamente |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |